GNMT expression is reduced in different liver diseases including liver cirrhosis of diverse etiology1,6, chronic cholestatic liver disease7, hepatocellular carcinoma (HCC)1, and cholangiocarcinoma2. Here, GNMT is linked to hepatocellular carcinoma.